One80 introduces GeneBridge reinsurance product for gene therapy

Share!

Reinsurance News - Jul 01, 2024

One80 Intermediaries (One80), an insurance broker based in Boston, announced the launch of GeneBridge, an innovative product designed to reduce the financial burden of high-cost gene therapy claims. Matthew Power, President, One80, commented: “With the number of gene and cell therapies expected to d...

Read Full Article

Recommended Articles

HSB to protect small businesses with new cyber insurance & incident response solution

Posted: Oct 07, 2025

HSB, a specialist engineering and technology insurer, has announced the launch of HSB CyberPro, a cy...

Nick Clay to lead Chubb’s Renewable Energy & Alternative Fuels Industry Practice

Posted: Oct 07, 2025

Global insurer Chubb has announced the appointment of Nick Clay as Renewable Energy & Alternativ...

Ransomware attacks to surge 40% by 2026 amid AI and cloud vulnerabilities: QBE

Posted: Oct 07, 2025

Ransomware attacks are predicted to escalate in the coming years, with the number of publicly named...